Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Brain Neoplasms 7Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasm Metastasis 1Lung Neoplasms 1

Interventions

Radiosurgery 33Radiotherapy 19Temozolomide 16Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 7Cyclophosphamide 7trastuzumab deruxtecan 4temsirolimus 4Sunitinib 4Specimen Handling 4Mental Status and Dementia Tests 4motexafin gadolinium 3fludarabine phosphate 3fludarabine 3aldesleukin 3Trastuzumab 3Pemetrexed 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Dexamethasone 3Capecitabine 3Bevacizumab 3pembrolizumab 2entrectinib 2efaproxiral 2Vinorelbine 2Topotecan 2Sorafenib 2Radiotherapy, Intensity-Modulated 2Quality of Life 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × icotinib × CNS × Clear all
NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Zhejiang Cancer Hospital

Phase 2 Completed
20 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡